Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed)
|
|
- Maximilian Houston
- 6 years ago
- Views:
Transcription
1 Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed) CLeAR Webinar February 14, 2014 Paula Diaz (Pharm) Carol Ward MD Carol Ward Tertiary Mental Health IHA
2 Hillside Centre (Acute Tertiary Mental Health Hospital IHA) Carol Ward Tertiary Mental Health IHA
3 Aim: Call for Less Antipsychotics in Residential Care (CLeAR) BC Patient Safety & Quality Council Achieve a reduction of 50% in the inappropriate use of antipsychotics in participating facilities across the province through evidence-based management of BPSD for seniors living in residential care by Dec. 31, 2014 Carol Ward Tertiary Mental Health IHA
4 Objectives Develop an understanding of the use of antipsychotics in the treatment of specific mental health disorders (Detect) Recognize the different classes of antipsychotics (typical and atypical) (Select) Review side-effects and related monitoring (Effect) Carol Ward Tertiary Mental Health IHA
5 Quick Facts: Mental Illness & Addiction in Canada (3 rd Ed) Mental illness is a serious disturbance in thoughts, feelings and perceptions that is severe enough to affect day to day functioning. Chances of having a mental illness in your lifetime 1 in 5 Carol Ward Tertiary Mental Health IHA
6 Quick Facts: Mental Illness & Addiction in Canada (3 rd Ed) At any given time percentage of Canadians who have mental illness:10.4% Lifetime Major Depression 8% Bipolar disorder 1% Schizophrenia 1% Anxiety disorder 12% Carol Ward Tertiary Mental Health IHA
7 Psychiatric Disorders in Late Life Mental illness does not discriminate; no one across the age span is immune to its effects (Mental Health Commission of Canada- Seniors Guidelines) Dignity Support Address Stigma Carol Ward Tertiary Mental Health IHA
8 Psychiatric Disorders in Late-Life (MHCC) Grow old with recurrent, persistent or chronic mental illness Develop late-onset mental illness Behavioural and Psychological Symptoms of Dementia (BPSD) associated with Major and Minor Neurocognitive Disorders (MCI/Dementia) Carol Ward Tertiary Mental Health IHA Chronic medical conditions with known neuropsychiatric symptoms (ie. Parkinson s Disease, stroke, COPD)
9 Prevalence of psychiatric disorders among older adults in LTC- a systematic review Dementia 58% (12-91%) BPSD in Dementia 78% (38-92%) Major Depressive Disorder 10% (5-25%) Clinically significant depressive symptoms 29% (14-82%) Other (Anxiety (3-10%),Schizophrenia (~6%),Bipolar Disorder (~3%) less well studied) Carol Ward Tertiary Mental Health IHA (Seitz D. et al, 2010)
10 Mental Health Issues in the Nursing Home (Conn D. The Canadian Review of Alzheimer s Disease 2007;9(1):12-17.) 80%-90% of NH residents suffer from a mental disorder >66% suffer from dementia 15%-25% have symptoms of major depression 77% have some degree of aggression or agitation 56% have delusions 33% have hallucinations Carol Ward Tertiary Mental Health IHA
11 Definition of Psychotropic Medication Psycho = the mind (Greek) Trop = a turning capable of turning the mind Any medication capable of affecting the mind, emotions and behaviour. (aka:psychodynamic, psychoactive, psychotherapeutic) Carol Ward Tertiary Mental Health IHA
12 Five Classes of Psychotropics 1. Antidepressants 2. Antipsychotics 3. Anxiolytics 4. Mood Stabilizers 5. Cognitive Enhancers Carol Ward Tertiary Mental Health IHA
13 Antipsychotics discovery of Chlorpromazine in 1952 surgical anesthetic ( calming effect ) discovered psychoactive effects great reduction in restraint, seclusion and sedation of agitated patients lead to research in other psychotropics Clozapine first atypical Carol Ward Tertiary Mental Health IHA
14 Antipsychotics classified based on chemical class and neuroreceptor affinity profiles antipsychotic activity absence of deep coma or anesthesia in large doses absence of physical or psychic dependence term tranquilizer and neuroleptic are outmoded Carol Ward Tertiary Mental Health IHA
15 Select (P.I.E.C.E.S.) What class of antipsychotic is it? Atypical Traditional Risperidone Olanzapine Quetiapine Clozapine Paliperidone Aripiprazole Ziprasidone Asenapine Lurasidone Haloperidol Loxapine Chlorpromazine Perphenazine Carol Ward Tertiary Mental Health IHA
16 DETECT When should antipsychotics be considered? Carol Ward Tertiary Mental Health IHA
17 Detect Antipsychotics may be used for: Specific treatment of a mental health disorder (DSM V). For example: Schizophrenia and related Psychotic Disorders Bipolar Disorder Major Depression psychotic and/or refractory Carol Ward Tertiary Mental Health IHA
18 Detect con t Antipsychotics may be used for: Supportive treatment. For example: Delirium Carol Ward Tertiary Mental Health IHA
19 Detect con t Antipsychotics may be used for: Treatment of a specific Behavioural and Psychological Symptoms of Dementia (BPSD): For example Delusions Hallucinations Physical/verbal aggression Manic-like Sexually inappropriate behaviour Carol Ward Tertiary Mental Health IHA
20 Reference Best Practice Guide for Accommodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care A Client Centered Interdisciplinary Approach B.C. Ministry of Health 2012 Carol Ward Tertiary Mental Health IHA
21 Algorithm Coming soon! Carol Ward Tertiary Mental Health IHA
22 The Algorithm is meant to be used from the top down: Part I: Interdisciplinary Decisional and Practice Support for BPSD: Assessment (green) Problem Solving (yellow) Care Planning (blue) Antifeau & Drance
23 Part 2: Reassessment with GP or NP for BPSD Re-assessment with medical lens Pharmacological considerations: behaviour that is dangerous, distressing, disturbing, and damaging/ & not responding Distinguish behaviours that are/are not likely to respond to medications Antifeau & Drance
24 Part 2: Reassessment with GP or NP for BPSD Behaviours that may respond to medications Second-line intervention support Evidence-informed behavioural categories: sleep disturbance, anxiety, psychosis, aggression, depression and sexually inappropriate behaviour. Antifeau & Drance
25 What are the challenges when prescribing antipsychotics to seniors? Which medication works for which behaviour? Right dose? Side effects? Tapering off medication Changing medication How long before we see desired effect? Drug interactions MDs not familiar with psychotropics Colleagues wanting a quick fix Haldol Wobble Colleagues with differing opinions about meds Not giving enough time for desired effect Difficult to monitor P. Diaz (Pharm)
26 Remember! Team and Comprehensive Approach Informed and involved: Person and family at the centre. Informed interdisciplinary and intersectoral providers working together and sharing information. Prevent the preventable; support the supportable, treat the treatable. (Duncan Robertson) P. Diaz (Pharm)
27 Antipsychotics P. Diaz (Pharm)
28 Psychotropic Framework (P.I.E.C.E.S. 6 th Ed) 1. Detect: When should a psychotropic be used or considered? 2. Select: How do I contribute to the selection of the right medication? 3. Effect: How do I monitor the response and side effects? P. Diaz (Pharm)
29 Antipsychotics Detect: When should it be considered? Clinical purpose: (1) Psychotic disorders (2) Dementia with specific BPSD target symptoms (aggression, psychosis) (3) Mood Disorders (4) Delirium P. Diaz (Pharm)
30 P. Diaz (Pharm)
31 Safety and Antipsychotics Over-sedation Postural Hypotension Impaired cognition Falls Weight gain Hyperglycaemia QTc prolongation Extra-pyramidal symptoms (EPS) Tardive Dyskinesia Cerebrovascular events Mortality (VCHA, Antipsychotic Guidelines BPSD, 2011) P. Diaz (Pharm)
32 Newer /Novel/Atypical Antipsychotics Select Less effects on: EPS Tardive dyskinesia Cognition A different set of concerns: Diabetes control/weight gain, cholesterol levels In dementia increase mortality? In dementia, risk of cardiovascular events? P. Diaz (Pharm)
33 Recently published article concludes deaths are due to symptoms rather than antipsychotic medications. P. Diaz (Pharm)
34 Parkinson s-like Symptoms Tremor Akinesia Akathisia Rigidity (cogwheel) Drooling Pisa Sign Rabbit Sign Gait disturbance P. Diaz (Pharm)
35 Should the Parkinson s- like symptoms be treated with medication? Anticholinergics such as benztropine NOT recommended in the elderly may worsen cognition, in addition can cause adverse effects such as dry mouth, constipation and urinary retention. Levodopa (e.g. sinemet) is for Parkinson's disease NOT for druginduced symptoms P. Diaz (Pharm)
36 Side Effect Profiles EPS Hyperlipidemia Weight Gain QTc Prolongation Sexual Dysfunction Sedation Aripiprazole Olanzapine Quetiapine Risperidone Ziprasidone EPS: extrapyramidal side effects Neutral - Low risk Moderate risk High risk Harrigan EP et al. J Clin Psychopharmacol. 2004;24(1): Keck PE et al. J Clin Psychiatry. 2006;67(4): Kim B et al. J Affect Disord. 2008;105(1-3): Miller D et al. J Clin Psychiatry. 2001;62(12): Olfson M, et al. Am J Psychiatry. 2006;163(10): Yatham LN et al. Bipolar Disord. 2009;11(3):
37 Newer Antipsychotics: Effect DASH Dizziness Agitation - Somnolence - Hypotension Olanzapine (anticholinergic) may cause weight gain, diabetic dyscontrol Risperidone may cause EPS at higher doses Quetiapine watch for sedation P. Diaz (Pharm)
38 Guidelines for Dosages in Dementia Risperdone 0.25 to 1.5 Target 1.0 mg Olanzapine 2.5 to 10 mg Aripiprazole 2 to 10 mg Quetiapine mg Note: may need to use higher dosages ( mg) for Quetiapine; always titrate to response and tolerability: GO SLOW P. Diaz (Pharm)
39 When should p.r.n. doses be used? Uses: Urgent situation ie. Physical aggression, acting on hallucination/delusion Pre-task ie. Bathing, x-ray, dental work Titration with goal of finding the therapeutic dose P. Diaz (Pharm)
40 Drug interactions a concern for elderly residents taking multiple medications Pharmacokinetic- a drug effects the absorption, distribution or metabolism/ excretion of another to alter the quantity of medication at the active site Pharmacodynamic- two or more drugs have additive or opposite beneficial or adverse effects at their receptors P. Diaz (Pharm)
41 Examples of Pharmacokinetic interactions with antipsychotics Quetiapine is primarily metabolised by an enzyme CYP3A4: Inducers (e.g. phenytoin and carbamazepine) will cause faster metabolism and less effect of quetiapine and higher doses may be required Inhibitors (e.g. erythromycin, grapefruit juice) can slow down the metabolism of quetiapine and lead to enhanced effects both beneficial and adverse P. Diaz (Pharm)
42 Examples of Pharmacodynamic drug interactions Additive sedation: opioids, benzodiazepines, zopiclone, sedating anti-depressants, anti-histamines Additive hypotension and dizziness: diuretics, ACE inhibitors, beta-blockers, calcium channel blockers, tamsulosin, terazosin Additive anti-cholinergic effects: oxybutynin, opioids, inhaled tiotropium/ipratropium Additive parkinsonian effects: SSRIs, metoclopramide, prochlorperazine P. Diaz (Pharm)
43 QTc Prolongation-detected by ECG Anti-psychotics have potential to prolong QTc, can lead to Torsade de Points, syncope and sudden death Risk factors: female, older age, bradycardia, low potassium and magnesium levels, liver or cardiac disease Effects of drugs may be additive extensive list includes: domperidone, SSRI e.g. citalopram, antibiotics e.g. clarithromycin, moxifloxacin, cardiac medications e.g. amiodarone, sotalol P. Diaz (Pharm)
44 Antipsychotic medication templates as part of the algorithm P. Diaz (Pharm)
45 Antipsychotic medication templates as part of the algorithm
46 THE END Carol Ward Tertiary Menatl Health IHA
Antipsychotics in Dementia
Antipsychotics in Dementia What s all the fuss? Judy MacDonald RPh BSc Pharm Dr. Ashok Krishnamoorthy MD MRCPsych FRCPC ABAM MS (Neuro Psych) Learning Objectives Recognize common behavioural & psychological
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationMedication Audit Checklist- Antipsychotics - Atypical
Medication Audit checklist Page 1 of 7 10-2018 Audit number: Client number: Ordering Provider: INDICATIONS 1) Disorders with psychotic symptoms (schizophrenia, schizoaffective disorder, manic disorders,
More informationChapter 161 Antipsychotics
Chapter 161 Antipsychotics Episode Overview Extrapyramidal syndromes are a common complication of antipsychotic medications. First line treatment is benztropine or diphenhydramine. Lorazepam is used in
More informationAntipsychotics. Something Old, Something New, Something Used to Treat the Blues
Antipsychotics Something Old, Something New, Something Used to Treat the Blues Objectives To provide an overview of the key differences between first and second generation agents To an overview the newer
More informationPsychosis and Agitation in Dementia
Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University
More informationObjectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia
Objectives Identify positive and negative symptoms used for diagnosis of schizophrenia Mohamed Sallout, Pharm D. Pharmacist Resident St. Luke s Magic Valley Regional Medical Center List medications used
More informationDebra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017
Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic
More informationDEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.
DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that
More informationAntipsychotic Use in the Elderly
Antipsychotic Use in the Elderly Presented by: Fatima M. Ali, PharmD, RPh, BCPS Clinical Consultant Pharmacist MediSystem Pharmacy, Kingston Originally Prepared by: Nicole Tisi BScPhm, RPh ACPR Disclosure
More informationObjectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition
Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change
More informationSchizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM
Schizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM NURS 203 GENERAL PHARMACOLOGY DANITA NARCISO PHARM D Learning Objectives Understand the result of dopamine binding to D2 receptors
More informationSwitching antipsychotics: Basing practice on pharmacology & pharmacokinetics
Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Switching Antipsychotics: Objectives
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationWhat Team Members Other Than Prescribers Need To Know About Antipsychotics
What Team Members Other Than Prescribers Need To Know About Antipsychotics The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State
More informationPresented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD
Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Define BPSD and review the spectrum of associated symptoms Review pharmacologic and non-pharmacologic treatments for BPSD Evaluate
More informationDisclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA
Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer
More informationOut with the Old In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications
Program Outline Out with the Old In with the New: Novel, Neuroscience-Based Re-Classification of Psychiatric Medications Rajiv Tandon, MD Professor of Psychiatry University of Florida College of Medicine
More informationTHIOTHIXENE. THERAPEUTICS Brands Navane see index for additional brand names. Generic? Yes
THIOTHIXENE THERAPEUTICS Brands Navane see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, thioxanthene, dopamine 2 antagonist) Commonly Prescribed for (bold
More informationMedicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationPERPHENAZINE. THERAPEUTICS Brands Trilafon see index for additional brand names. Generic? Yes
PERPHENAZINE THERAPEUTICS Brands Trilafon see index for additional brand names Generic? Yes Class Neuroscience-based Nomenclature: dopamine receptor antagonist (D-RAn) Conventional antipsychotic (neuroleptic,
More informationAntipsychotics. Neuroleptics/ Major Tranquilizers. Hiwa K. Saaed, PhD Pharmacology & Toxicology /5/18 1
Antipsychotics Neuroleptics/ Major Tranquilizers Hiwa K. Saaed, PhD Pharmacology & Toxicology hiwa.saaed@univsul.edu.iq 2018-2019 12/5/18 1 Learning objectives Pharmacy students should: be familiar with
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationThe antipsychotic drugs (also called neuroleptics or major tranquilizers) are used primarily to treat schizophrenia, but they are also effective in
Antipsychotic Drugs The antipsychotic drugs (also called neuroleptics or major tranquilizers) are used primarily to treat schizophrenia, but they are also effective in other psychotic and manic states.
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationBehavioural and Psychological Symptoms and Medications Presentation
1 2 Vover s research indicated that antipsychotic med are frequently used for individual presenting with disruptive behaviours. This often combined with physical restraints Efficacy of use not justify
More informationPERPHENAZINE. THERAPEUTICS Brands Trilafon see index for additional brand names. Generic? Yes
PERPHENAZINE THERAPEUTICS Brands Trilafon see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, phenothiazine, dopamine 2 antagonist, antiemetic) Commonly Prescribed
More informationDEMENTIA AND MEDICATION
DEMENTIA AND MEDICATION Dr. Siobhan Ni Bhriain, MRCP, MRCPsych. Clinical Director, Tallaght and SJH MHS, Consultant Old Age Psychiatrist, Chair, DSIDC Steering Committee. SUMMARY OF TODAY S TALK Dementia-definition,
More informationTreat Schizophrenia Schizoaffective disorder Bipolar disorder Psychotic depression Off-label uses Insomnia Tics Delirium Stuttering
Robert M. Millay RN MSN Ed Professor, Napa Valley College Psychiatric Technician Programs Copyright 2015, 2011, 2007, 2003, 1999, 1995, 1991 by Mosby, an imprint of Elsevier Inc. Treat Schizophrenia Schizoaffective
More informationHearts and Minds An ECG Update. Tuesday 18 th November The Met Hotel, Leeds
Hearts and Minds An ECG Update Tuesday 18 th November The Met Hotel, Leeds Ashleigh Bradley Specialist Clinical Pharmacist for Mental Health and Lithium Clinic Airedale NHS Foundation Trust Introduction
More informationA Basic Approach to Mood and Anxiety Disorders in the Elderly
A Basic Approach to Mood and Anxiety Disorders in the Elderly November 1 2013 Sarah Colman MD FRCPC Clinical Fellow, Geriatric Psychiatry Mount Sinai Hospital, University of Toronto Disclosure No conflict
More informationExtrapyramidal Symptoms Associated with Antipsychotic Use
Extrapyramidal Symptoms Associated with Antipsychotic Use Tamara Pringsheim, MD, FRCPC, FAAN Associate Professor, University of Calgary Department of Clinical Neurosciences, Psychiatry, Pediatrics and
More informationPreventing Falls in Older Adults A Matter of Safety
Preventing Falls in Older Adults A Matter of Safety Roger Tam, BSc. Pharm. Wal-Mart Clinical Designated Pharmacist Falls Prevention Pharmacist Specialist NCCHC-Pre/Post Test Educator Q.U.I.T Educator Overview
More informationBehavioral and Psychological Symptoms of dementia (BPSD)
Behavioral and Psychological Symptoms of dementia (BPSD) Chris Collins - Old Age Psychiatrist, Christchurch chris.collins@cdhb.health.nz Approaching BPSD: the right mindset Assessment Non-drug management
More informationPRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
More informationDelirium. Dr. Lesley Wiesenfeld. Deputy Psychiatrist in Chief, Mount Sinai Hospital. Dr. Carole Cohen
Delirium Dr. Lesley Wiesenfeld Deputy Psychiatrist in Chief, Mount Sinai Hospital Dr. Carole Cohen Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre Case Study Mrs B
More informationAntidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych
Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.
More informationWESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS
WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS DOPAMINE HYPOTHESIS Excessive limbic dopamine is hypothesised to cause psychosis Many antipsychotics inhibit dopamine 2 receptors in mesolimbic and
More informationBehavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.
Behavioral Issues in Dementia March 27, 2014 Dylan Wint, M.D. OVERVIEW Key points Depression Definitions and detection Treatment Psychosis Definitions and detection Treatment Agitation SOME KEY POINTS
More informationANTIPSYCHOTICS AGENTS CONVENTIONAL
ANTIPSYCHOTICS AGENTS CONVENTIONAL Documentation A. FDA approved indications 1. Psychotic Disorder (Haloperidol, Thiothixene) 2. Schizophrenia 3. Bipolar Disorder, Manic (Chlorpromazine) 4. Severe Behavioral
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationDiagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical
Diagnosis and treatment of acute agitation and aggression in patients with schizophrenia and bipolar disorder: evidence for the efficacy of atypical antipsychotics 1 Abstract Acute agitation and aggression
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Pretest 1. Appropriate target symptoms for emergency room medication treatment
More informationSCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS
1 SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS OBJECTIVES 2 Know and understand: How to evaluate a person with psychotic symptoms The epidemiology and clinical characteristics of lateonset schizophrenia
More informationAlison Charleston 1 st September 2016
Alison Charleston 1 st September 2016 Clinical features of Parkinson s disease Differential diagnosis Management of the motor features Non-motor and neuropsychiatric aspects 100-200 per 100,000 prevalence
More informationAssessment and management of behavioral and psychological symptoms of dementia
Assessment and management of behavioral and psychological symptoms of dementia Helen C Kales, 1 2 3 Laura N Gitlin, 4 5 6 Constantine G Lyketsos 7 1 Section of Geriatric Psychiatry, Department of Psychiatry,
More informationTRIFLUOPERAZINE. THERAPEUTICS Brands Stelazine see index for additional brand names
TRIFLUOPERAZINE THERAPEUTICS Brands Stelazine see index for additional brand names Generic? Yes Class Neuroscience-based Nomenclature: dopamine receptor antagonist (D-RAn) Conventional antipsychotic (neuroleptic,
More informationS H A R E D P R E S C R I B I N G G U I D E L I N E
S H A R E D P R E S C R I B I N G G U I D E L I N E Introduction This shared prescribing guideline for the second generation antipsychotic medications listed above has been developed with due consideration
More informationKelly Godecke, MD Department of Psychiatry University of Utah
Kelly Godecke, MD Department of Psychiatry University of Utah Epidemiology and Impact -module 2 session 1 overview of mood disorders Diagnostic Criteria of Bipolar Disorders Medications Used in Bipolar
More informationBest Practice Guideline for Accommodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care
Best Practice Guideline for Accommodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care A Person-Centered Interdisciplinary Approach October 25, 2012 Acknowledgements
More informationSeniors Health Strategic Clinical Network Restraint as a Last Resort
Seniors Health Strategic Clinical Network Restraint as a Last Resort Elder Friendly Care 2018 Alberta Health Services, Seniors Health Strategic Clinical Network Disclaimer, Copyright and Creative Commons
More informationANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?
ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good? STEPHANIE M. OZALAS, PHARMD, BCPS, BCGP VA MARYLAND HEALTH CARE SYSTEM BALTIMORE, MD DISCLOSURES Off-label use of medications will be
More informationPharmacological Treatment of Aggression in the Elderly
Pharmacological Treatment of Aggression in the Elderly Howard Fenn, MD Adjunct Clinical Associate Professor Department of Psychiatry and Behavioral Sciences Stanford University Self-Assessment Question
More informationAntipsychotic Medication
Antipsychotic Medication Mary Knutson, RN 3-7-12 Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Clinical Uses of Antipsychotics Short-term: in severe depression and
More information( delirium ) 15%- ( extrapyramidal syndrome ) risperidone olanzapine ( extrapyramidal side effect ) olanzapine ( Delirium Rating Scale, DRS )
2005 6 48-52 Olanzapine 30% ( delirium 5%- Haloperidol ( extrapyramidal syndrome risperidone ( extrapyramidal side effect ( Delirium Rating Scale, DRS ( Delirium ( Olanzapine ( Delirium Rating Scale, DRS
More informationAntipsychotics for Dementia Under Control or Over-Prescribed?
Antipsychotics for Dementia Under Control or Over-Prescribed? Nathaniel Hedrick, PharmD ProCare HospiceCare, Manager of Clinical Services Learning Objectives Summarize the disease progression and most
More informationDepression in Late Life
Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan Pretest 1. Which of the following conditions is LEAST likely to benefit from emergency
More informationThe place for treatments of associated neuropsychiatric and other symptoms
The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public
More informationDosing & Administration
Dosing & Administration REAL LIFE. REAL RESULTS. INDICATION INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia. Schizoaffective disorder as monotherapy and as an
More informationLOXAPINE. THERAPEUTICS Brands Loxitane Adasuve (Staccato loxapine, inhaled loxapine) see index for additional brand names. Generic?
LOXAPINE THERAPEUTICS Brands Loxitane Adasuve (Staccato loxapine, inhaled loxapine) see index for additional brand names Generic? Yes Class Neuroscience-based Nomenclature: dopamine and serotonin receptor
More informationSilvia Duong, 1,2 Kam-Tong Yeung, 1 and Feng Chang 1,3. 1. Introduction
Aging Research Volume 2015, Article ID 570410, 6 pages http://dx.doi.org/10.1155/2015/570410 Research Article Intramuscular Olanzapine in the Management of Behavioral and Psychological Symptoms in Hospitalized
More informationPsychotropic Medication. Including Role of Gradual Dose Reductions
Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which
More informationChapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses
Chapter 17 Psychoses Drugs for Psychoses Delusions Hallucinations Illusions Paranoia Upper Saddle River, New Jersey 07458 All rights reserved. Classifications of Psychoses Acute episode Chronic episode
More informationDelirium. Assessment and Management
Delirium Assessment and Management Goals and Objectives Participants will: 1. be able to recognize and diagnose the syndrome of delirium. 2. understand the causes of delirium. 3. become knowledgeable about
More informationMedicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay
Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay (Revised edition November 2015) The Medicine Related Falls Risk Assessment
More informationASENAPINE. THERAPEUTICS Brands SAPHRIS see index for additional brand names
ASENAPINE THERAPEUTICS Brands SAPHRIS see index for additional brand names Generic? No Class Neuroscience-based Nomenclature: dopamine, serotonin, norepinephrine receptor antagonist (DSN-RAn) Atypical
More informationSECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS
SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS Formulary and Prescribing Guidelines 9.1 Introduction Movement disorders and extrapyramidal side effects can manifest in the
More information9/11/2012. Clare I. Hays, MD, CMD
Clare I. Hays, MD, CMD Review regulatory background for current CMS emphasis on antipsychotics Understand the risks and (limited) benefits of antipsychotic medications Review non-pharmacologic management
More informationPsychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD
Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences
More informationDelirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care
Delirium A Plan to Reduce Use of Restraints David Wensel DO, FAAHPM Medical Director Midland Care Objectives Define delirium Describe pathophysiology of delirium Understand most common etiologies Define
More informationPharmacotherapy of psychosis and schizophrenia in youth
Pharmacotherapy of psychosis and schizophrenia in youth Benedetto Vitiello Pavia, 2 December 2017 Disclosure Benedetto Vitiello, M.D. Professor of Child and Adolescent Neuropsychiatry University of Turin,
More informationNew Medications in Early Psychosis
New Medications in Early Psychosis Jean Starling Department of Psychological Medicine, the Children s Hospital at Westmead Department of Psychological Medicine and Department of Paediatrics and Child Health,
More informationLURASIDONE. THERAPEUTICS Brands LATUDA see index for additional brand names
LURASIDONE THERAPEUTICS Brands LATUDA see index for additional brand names Generic? No Class Neuroscience-based Nomenclature: dopamine, serotonin receptor antagonist (DS-RAn) Atypical antipsychotic (serotonin-dopamine
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationAntidepressants. Dr Malek Zihlif
Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric
More informationUse of Psychotropic Medications in Older Adults with Dementia!
Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with
More informationSlide 1. Slide 2. Slide 3. Risperidone Binding Profile. Risperidone Prescribing Facts. Risperidone Prescribing Facts
Slide 1 Risperidone Binding Profile (high affinity for D2 receptors) a 1 antagonist a 2 antagonist Slide 2 Risperidone Prescribing Facts 2 8 mg/day for acute psychosis and bipolar disorder 0.5-2 mg /day
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationAntipsychotics. This factsheet covers -
Antipsychotics If you experience psychosis as part of an illness, you may be offered antipsychotic medication. Antipsychotics are generally used to treat psychosis, but are also used to treat bipolar disorder
More informationCognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics
Cognitive enhancers PINCH ME Anticholinergic burden BPSD Agitation, Aggression and antipsychotics 2 types Cholinesterase inhibitors licensed for mild to moderate AD Donepezil Galantamine Rivastigmine also
More informationHow did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh
Polypharmacy, Adverse Effects, and the Importance of Tapering Medications for People with Intellectual and Developmental Disabilities Garrett McCann, RPh How did we get here? 1876 Methylene Blue Insecticide
More informationFormulary and Clinical Guideline Document Pharmacy Department Medicines Management Services
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services VIOLENCE, AGGRESSION OR SEVERE BEHAVIOURAL DISTURBANCE Introduction During an acute episode or illness, some
More informationEnhanced Primary Care Pathway: Parkinson s Disease
Enhanced Primary Care Pathway: Parkinson s Disease 1. Focused summary of PD relevant to primary care Parkinson s Disease (PD) and Essential tremor (ET) are two of the most common movement disorders encountered
More informationAntipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011)
Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011) Introduction Antipsychotics are the foundation of pharmacological treatment of schizophrenia and other psychotic illnesses.
More informationRestrained use of antipsychotic medications:
Balanced information for better care Restrained use of antipsychotic medications: Rational management of irrationality These drugs are commonly prescribed in conditions for which there is little evidence
More informationIntroduction to psychotropic medications JAYNE CAMPBELL
Introduction to psychotropic medications JAYNE CAMPBELL Introduction Psychotropic medications are prescription drugs that are commonly used to control some symptoms associated with many different types
More informationCHAPTER 3. Schizophrenia and Antipsychotic Treatment
CHAPTER 3 Schizophrenia and Antipsychotic Treatment What is it? It is a severe, chronic, disabling brain disease Considered to have biological origins but exact unknown 1% of population affected Schizophrenia
More informationNuplazid. (pimavanserin) New Product Slideshow
Nuplazid (pimavanserin) New Product Slideshow Introduction Brand name: Nuplazid Generic name: Pimavanserin Pharmacological class: Atypical antipsychotic Strength and Formulation: 17mg; tablets Manufacturer:
More informationThe Maudsley Prescribing Guidelines in
The Maudsley Prescribing Guidelines in 11th Edition David Taylor Director of Pharmacy and Pathology South London and Maudsley NHS Foundation Trust; Professor King's College London, London, UK Paton Chief
More informationThis factsheet covers:
Antipsychotics If you experience psychosis as part of your illness, you may be offered antipsychotic medication. Antipsychotics are generally used to treat psychosis, but are also used to treat bipolar
More informationSymbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination)
Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination) Generic name: Olanzapine and fluoxetine combination Available strengths: 6 mg/25 mg, 6 mg/50 mg, 12 mg/25 mg, 12 mg/50 mg (Zyprexa/Prozac)
More informationQuetiapine Case 2 Therapeutic Drug Monitoring Jose de Leon, MD
Quetiapine Case 2 Therapeutic Drug Monitoring 1-27-16 Jose de Leon, MD 2. Quetiapine Case Therapeutic Drug Monitoring (unpublished) Educational Objectives At the conclusion of this presentation, the participant
More informationBLONANSERIN. THERAPEUTICS Brands Lonasen see index for additional brand names
BLONANSERIN THERAPEUTICS Brands Lonasen see index for additional brand names Generic? No Class Atypical antipsychotic (serotonin dopamine antagonist; second-generation antipsychotic; also a potential mood
More informationCHLORPROMAZINE. THERAPEUTICS Brands Thorazine see index for additional brand names
CHLORPROMAZINE THERAPEUTICS Brands Thorazine see index for additional brand names Generic? Yes Class Neuroscience-based Nomenclature: dopamine and serotonin receptor antagonist (DS-RAn) Conventional antipsychotic
More informationSymptoms of schizophrenia are usually categorized as positive
PHARMACOLOGY NOTES Ziprasidone mesylate (Geodon for injection): the first injectable atypical antipsychotic medication VALERIE SHEEHAN, PHARMD Symptoms of schizophrenia are usually categorized as positive
More informationManagement of Delirium in Hospice Patients
Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying
More informationCYAMEMAZINE. THERAPEUTICS Brands Tercian see index for additional brand names
CYAMEMAZINE THERAPEUTICS Brands Tercian see index for additional brand names Generic? Not in the USA Class Conventional antipsychotic (neuroleptic, phenothiazine, dopamine 2 antagonist, serotonin dopamine
More information